Breaking News

Aptuit Acquires Kuecept

Expands capabilities to support preclinical drug development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Aptuit, LLC has acquired Kuecept Ltd., expanding capabilities for specialist drug pre-formulation, formulation prototyping and formulation development services.   Kuecept, based in London, offers technical expertise in CRO services supporting preclinical drug development. Kuecept provides pre-formulation testing, preclinical dose-vehicle screening and formulation development, along with a range of enabling drug delivery technologies. Kuecept has experience in respiratory, parenteral and oral f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters